Search

Search Results

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Pharmacoeconomic Analysis of R-DA-EPOCH and R-mNHL-BFM-90 Combination Immunochemotherapy in Patients with Prognostically Unfavorable Diffuse Large B-Cell Lymphoma within Randomized Multi-Center Clinical Trial DLBCL-2015

  Madina Olegovna Bagova, A.U. Magomedova, S.K. Kravchenko, R.I. Yagudina, V.G. Serpik, S.M. Kulikov, Yu.A. Chabaeva

  321-332

  01.07.2021

• Hodgkin’s Lymphoma: Analysis Results of Volgograd Regional Registry

  Kamil Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian

  363-376

  01.10.2019

• Primary Mediastinal (Thymic) Large B-Cell Lymphoma: Experience in Treating 131 Patients at a National Medical Research Center in Russia

  I.Z. Zavodnova, M.Yu. Kichigina, E.V. Paramonova, Yu.E. Ryabukhina, O.A. Kolomeitsev, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, N.V. Kokosadze, Gayane Sergeevna Tumyan

  59-67

  01.01.2019

• PD-1 Blockade with Nivolumab as a New Immunotherapy for Classical Hodgkin’s Lymphoma

  Elena Andreevna Demina

  213-219

  01.07.2018

• First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan

  150-159

  01.04.2018

• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy

  Vasilii Anatol’evich Shuvaev, S.V. Voloshin, A.K. Hadzhidis, A.V. Chechetkin

  435-442

  01.10.2017

• Supportive (Maintenance) Therapy in Hematopoietic Stem Cell Transplantation: Main Principles and New Perspectives

  Vasilii Petrovich Pop, O.A. Rukavitsyn

  501-513

  01.10.2017

• Treatment of Drug-Resistant Mycosis Fungoides and Sezary Syndrome

  Liliya Gamilevna Gorenkova, E.A. Penskaya, S.K. Kravchenko, A.M. Kovrigina, T.N. Moiseeva, A.I. Vorob’ev

  366-371

  01.07.2017

• Pomalidomide in Combination with Low-Dose Dexamethasone as the Treatment of “Double Refractory” Multiple Myeloma

  Aleksei Vladilenovich Petrov, D.V. Motorin, O.S. Pokrovskaya, E.S. Urnova, M.V. Nareiko, D.V. Babenetskaya, Yu.A. Alekseeva, L.L. Girshova, L.P. Mendeleeva, A.Yu. Zaritskii

  372-380

  01.07.2017

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

  Tat’yana Ivanovna Ionova, N.B. Bulieva, O.Yu. Vinogradova, T.A. Gritsenko, L.K. Kozlova, G.B. Kuchma, E.G. Lomaia, E.R. Machyulaitene, T.P. Nikitina, N.V. Novitskaya, A.Yu. Rodionova, E.I. Usacheva, T.V. Shneider

  206-217

  01.04.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas

  Elena Andreevna Demina

  398-405

  01.10.2016

• Prevention of Acute Graft-Versus-Host Reaction after Allogeneic Unrelated Hematopoietic Stem Cell Transplantation: Comparison of Effectiveness of Treatment Regimens Based on Anti-Thymocyte Globulin and Cyclophosphamide

  Ol’ga Vladislavovna Pirogova, I.S. Moiseev, E.V. Babenko, O.A. Slesarchuk, O.V. Paina, S.N. Bondarenko, E.V. Morozova, A.L. Alyanskii, B.V. Afanas’ev

  391-397

  01.10.2016

• Anemias in Oncology: Potential of Maintenance Therapy

  Anton Vladimirovich Snegovoi, V.B. Larionova, L.V. Manzyuk, I.B. Kononenko

  326-335

  01.07.2016

• Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells

  Maksim Anatol’evich Kucher, М.S. Motalkina, О.U. Klimova, Е.V. Kondakova, О.B. Kalashnikova, S.М. Alekseev, D.V. Motorin, D.V. Babenetskaya, E.I. Podol’tseva, N.B. Mikhailova, М.А. Estrina, Е.V. Babenko, A.Yu. Zaritskii, B.V. Afanas’ev

  155-161

  01.04.2016

• Epstein-Barr Virus and Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevich

  101-114

  01.04.2016

• Treatment of Relapsed and Refractory Hodgkin’s Lymphoma in Children

  N.S. Kulichkina, E.S. Belyaeva, G.L. Mentkevich, V.K. Boyarshinov, A.S. Levashov, I.V. Glekov, Aleksandr Valentinovich Popa

  13-21

  01.01.2016

• Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

  Sergei Vasil’evich Gritsaev, I.I. Kostroma, A.A. Kuzyaeva, I.M. Zapreeva, E.V. Litvinskaya, L.V. Stel’mashenko, S.A. Tiranova, I.S. Martynkevich, N.A. Potikhonova, K.M. Abdulkadyrov

  48-53

  01.01.2016

• Prevention of Nausea and Vomiting in Oncology

  Anton Vladimirovich Snegovoi, V.B. Larionova, I.B. Kononenko, L.V. Manzyuk, A.I. Saltanov, V.Yu. Sel’chuk

  75-83

  01.01.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Polycythemia Vera: Literature Review and Own Data

  Irina Nikolaevna Subortseva, T.I. Kolosheinova, E.I. Pustovaya, E.K. Egorova, A.M. Kovrigina, Yu.V. Pliskunova, T.V. Makarik, A.O. Abdullaev, A.L. Melikyan

  397-412

  01.10.2015

• Treatment of Advanced Stage Hodgkin’s Lymphoma: Literature Review

  Anna Aleksandrovna Leont’eva, E.A. Demina

  255-266

  01.07.2015

• Modern Approaches to Diagnosis and Treatment of Essential Thrombocythemia: Literature Review and Own Experience

  K.M. Abdulkadyrov, Vasilii Anatol’evich Shuvaev, I.S. Martynkevich

  235-247

  01.07.2015

• Multiple Myeloma: 7-Year Experience of Applying Targeted Therapy in Novosibirsk and Its Results

  T.I. Pospelova, Nataliya Valer’evna Skvortsova, I.N. Nechunaeva

  267-273

  01.07.2015

• First Line Treatment Choice for Chronic Myelogenous Leukemia: Modeling of Clinical and Economic Factors

  Vasilii Anatol’evich Shuvaev, K.M. Abdulkadyrov, I.S. Martynkevich, M.S. Fominykh

  78–83

  01.01.2015

• Value of Patient-Reported Outcomes in Oncohematology

  T.I. Ionova, S. Salek, Е. Оliva

  573-576

  01.10.2014